Ultracompact monolithic integration of balanced, polarization diversity photodetectors for coherent lightwave receivers

The authors have monolithically integrated an optical front-end on InP for balanced, polarization-diversity coherent lightwave reception which is only 1.3-mm long. Low on-chip insertion loss (<4.5 dB) and balanced photoresponse (1.05:1 or better) are achieved at 1.5-μm wavelength using straightforward, regrowth-free fabrication. Low-capacitance photodetectors (≤0.15 pF) are employed for high bandwidth operation

Low-loss, Ultra-compact Monolithic Integration Of High-speed Polarization-diversity Photodetectors

Polarization-selective optical devices are required for polarization-diversity coherent lightwave receivers.[l] Monolithic integration of such devices with photodetectors improves detector functionality and eliminates package complexity by reducing part count and hybrid optical interconnects. Compatibility with high III-V materials' cost, however, requires simple, high-yield processes and compact device size. We previously proposed a simple and compact integration scheme employing metal-loaded vertical couplers for polarization splitting and vertically-coupled photodiodes for O/E conversion. Initial experiments using InGaAsP/InP demonstrated satisfactory optical functionality, with 10.6 and 16dB polarization selectivity for TE and TM polarized-light.[2] Here we show how such integrated devices can be modified to achieve suitable electronic performance, including wide bandwidth and high quantum efficiency

The effects of non-universal extra dimensions on the radiative lepton flavor decays \mu\to e\gamma and \tau\to \mu\gamma in the two Higgs doublet model

We study the effect of non-universal extra dimensions on the branching ratios of the lepton flavor violating processes \mu\to e\gamma and \tau\to \mu\gamma in the general two Higgs doublet model. We observe that these effects are small for a single extra dimension, however, in the case of two extra dimensions there is a considerable enhancement in the additional contributions.Comment: 16 Pages, 9 Figure

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network

Treatment challenges in and outside a network setting: Head and neck cancers

Head and neck cancer (HNC) is a rare disease that can affect different sites and is characterized by variable incidence and 5-year survival rates across Europe. Multiple factors need to be considered when choosing the most appropriate treatment for HNC patients, such as age, comorbidities, social issues, and especially whether to prefer surgery or radiation-based protocols. Given the complexity of this scenario, the creation of a highly specialized multidisciplinary team is recommended to guarantee the best oncological outcome and prevent or adequately treat any adverse effect. Data from literature suggest that the multidisciplinary team-based approach is beneficial for HNC patients and lead to improved survival rates. This result is likely due to improved diagnostic and staging accuracy, a more efficacious therapeutic approach and enhanced communication across disciplines. Despite the benefit of MTD, it must be noted that this approach requires considerable time, effort and financial resources and is usually more frequent in highly organized and high-volume centers. Literature data on clinical research suggest that patients treated in high-accrual centers report better treatment outcomes compared to patients treated in low-volume centers, where a lower radiotherapy-compliance and worst overall survival have been reported. There is general agreement that treatment of rare cancers such as HNC should be concentrated in high volume, specialized and multidisciplinary centers. In order to achieve this goal, the creation of international collaboration network is fundamental. The European Reference Networks for example aim to create an international virtual advisory board, whose objectives are the exchange of expertise, training, clinical collaboration and the reduction of disparities and enhancement of rationalize migration across Europe. The purpose of our work is to review all aspects and challenges in and outside this network setting planned for the management of HNC patients